2018 Speakers to be released shortly


2017 SPEAKERS

(Alphabetical)

Michael P. Bogenschutz, M.D.
Research Professor of Psychiatry at NYU Langone Medical Center
"A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence"

Thomas Kingsley Brown, Ph.D.
Researcher at Multidisciplinary Association for Psychedelic Studies (MAPS) and Coordinator of McNair Scholars Program at UC San Diego
"A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence"

Shannon Clare Carlin, M.A., IMF,
MAPS Public Benefit Corporation (MPBC) Therapy Training Program Manager, Zendo Project Integration Coordinator, Co-therapist in MAPS-Sponsored Clinical Trials
"Vision Becomes Reality: the Making of a Legal MDMA Therapist Through Recent Research”

Neşe Devenot, Ph.D.
Andrew W. Mellon Postdoctoral Fellow in Digital Humanities, University of Puget Sound
"The Role of Poetic Language in Psychedelic Science"

Holly Duane
Therapist, NYU School of Medicine Psilocybin-Assisted Treatment of Alcohol Dependence, and Clinical Trial on the Effects of Psilocybin-Generated Mystical Experience in Religious Leaders
"A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence"

Amanda Feilding
Founder and Director of the Beckley Foundation
"From The Mystical Experience to Microdosing"

Débora González, Ph.D.
Clinical Psychologist and Pharmacologist with the ICEERS Foundation
"The Therapeutic Potential of Altered States of Consciousness in Grieving Processes"

Rob Heffernan
Ayahuasca Defense Fund Associate, Independent Researcher, Activist“Guard-en-ing the Gates of Heaven: Protecting and Cultivating the Legality, Health and Safety of Sacred Medicines”

Mendel Kaelen, Ph.D.
Postdoctoral Research Associate, Imperial College London
"Music in Psychedelic Therapy"

Anja Loizaga-Velder, Ph.D.
Postdoctoral Research Associate, Faculty of Medicine, National Autonomous University of Mexico (UNAM); Director of Psychotherapy and Research, Nierika Institute for Intercultural Medicine- Mexico
“New Psychotherapeutic Perspectives With Ancient Medicines”

Elizabeth M. Nielson, Ph.D.
Psychologist, Department of Psychiatry, NYU Langone Medical Center
"What Psychedelic Therapists Don't Talk About and Why: The Case for Research on First-hand Experience with Psychedelics"

Nicholas Byron Powers, Ph.D.
Poet, journalist, and Associate Professor of English, SUNY Old Westbury
"Black Masks, Rainbow Bodies: Race and Psychedelics"

Stacy B. Schaefer, Ph.D.
Professor Emerita in the Department of Anthropology, California State University, Chico (CSUC) and former Co-Director of the Museum of Anthropology (CSUC)
"Communing with the Gods: Peyote (Lophophora williamsii) in the Lifecycle of Huichol Indians of Mexico"

Philip E. Wolfson, M.D.
Psychiatrist, psychotherapist, and Principal Investigator, MAPS MDMA-Assisted Psychotherapy for Anxiety Associated with Life-Threatening Illness Study
"Ketamine Assisted Psychotherapy and the Ketamine Opportunity"


2016 SPEAKERS

(Alphabetical)

Alicia Danforth, Ph.D.
Clinical Psychologist and Researcher, Los Angeles Biomedical Research Institute at the Harbor-UCLA Medical Center
“Exploring MDMA-Assisted Therapy as a Social Adaptability Catalyst for Autistic Adults”

Jag Davies
Director of Communications Strategy, Drug Policy Alliance
“Envisioning Success: What Does the End of Psychedelic Criminalization Look Like?”

Rick Doblin, Ph.D.
MAPS Founder and Executive Director
“Rescheduling MDMA: History and Future"

Natalie Lyla Ginsberg
MAPS Policy and Advocacy Manager
“Rescheduling MDMA: History and Future"

Ingmar Gorman, Ph.D.
Administrative Director of the Psychedelic Education and Continuing Care Program
“Psychedelic Integration: From the Individual to the Community”

Roland Griffiths, Ph.D.
Professor in the Departments of Psychiatry and Neurosciences, Johns Hopkins University School of Medicine
“The Johns Hopkins Psilocybin Research Project: Psilocybin-Occasioned Mystical-Type Experiences: Implications for Spirituality, Altruism, and Therapeutics”

Jesse Jarnow
Author, Heads: A Biography of Psychedelic America
"An Alternate and Ongoing History of Psychedelics"

Robert Jesse
Convener of the Council on Spiritual Practices
"Psychedelics: The Uncertain Paths From Re-emergence to Renaissance"

Bia Labate, Ph.D.
Visiting Professor at the Center for Research and Post Graduate Studies in Social Anthropology (CIESAS) in Guadalajara, Mexico
“The Field of Ayahuasca Research: A Retrospective"

Katherine Maclean, Ph.D.
Director, Psychedelic Education and Continuing Care Program, Center for Optimal LIving
“Psychedelic Integration: From the Individual to the Community"

Sarah Mennenga, Ph.D.
Postdoctoral Fellow, Department of Psychiatry, NYU Langone School of Medicine
“The NYU Psilocybin Project: History and Future”

Michael Mithoefer, M.D.
Lead Clinical Investigator and Medical Monitor, MDMA-Assisted Psychotherapy for PTSD
"MDMA-Assisted Psychotherapy Research: An Update on 12 Years of Successful Clinical Trials"

Jessica Nielson, Ph.D.
Assistant Professional Researcher for the Department of Neurosurgery at the Brain and Spinal Injury Center University of California, San Francisco
"Ayahuasca for PTSD: Assessing Benefits and Risks Through Multiple Perspectives"

Samantha Podrebarac, M.Sc.
Clinical Research Coordinator with the NYU Experimental Therapeutics Research Group
“The NYU Psilocybin Project: History and Future”

Stephen Ross, M.D.
Associate Professor of Psychiatry and Child & Adolescent Psychiatry at New York University School of Medicine
“The NYU Psilocybin Project: History and Future”

Ellen Spiro
Professor of Radio, TV, Film at the University of Texas in Austin
“The Field of Ayahuasca Research: A Retrospective"

Fred Tomaselli
Artist
"My Chemical Sublime"

Kenneth Tupper, Ph.D.
Adjunct Professor, School of Population and Public Health, University of British Columbia
“Beyond Healing: Psychedelics as Cognitive Tools for Learning”